Skip to main content
. 2012 Nov 9;7(11):e48950. doi: 10.1371/journal.pone.0048950

Figure 5. Survival pathway analysis.

Figure 5

TUDCA treatment upregulated ERK1/2 following ischemia-reperfusion injury to the kidney in rats (top panel); however, there was no statistical significant difefrence as compared to the vehicle-treated rats (top panel). There was no difference in JNK and p38 proteins between the TUDCA and vehicle groups. Densitometry analysis of ERK1/2 in each rat in the TUDCA group were compared with those in the vehicle group (lower panel); the difference was not significant (p  = 0.29). Results are expressed as mean ± standard deviation of a least 3 different animals in each group.